| 000 | 01476 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518072229.0 | ||
| 264 | 0 | _c20200413 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1422-0067 | ||
| 024 | 7 |
_a10.3390/ijms20235885 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakamura, Kazufumi | |
| 245 | 0 | 0 |
_aCurrent Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension. _h[electronic resource] |
| 260 |
_bInternational journal of molecular sciences _cNov 2019 |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 5 _xgenetics |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xtherapeutic use |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aPulmonary Arterial Hypertension _xdrug therapy |
| 650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
| 700 | 1 | _aAkagi, Satoshi | |
| 700 | 1 | _aEjiri, Kentaro | |
| 700 | 1 | _aYoshida, Masashi | |
| 700 | 1 | _aMiyoshi, Toru | |
| 700 | 1 | _aToh, Norihisa | |
| 700 | 1 | _aNakagawa, Koji | |
| 700 | 1 | _aTakaya, Yoichi | |
| 700 | 1 | _aMatsubara, Hiromi | |
| 700 | 1 | _aIto, Hiroshi | |
| 773 | 0 |
_tInternational journal of molecular sciences _gvol. 20 _gno. 23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/ijms20235885 _zAvailable from publisher's website |
| 999 |
_c30355936 _d30355936 |
||